Citigroup Inc. boosted its holdings in agilon health, inc. (NYSE:AGL - Free Report) by 2,251.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,028,246 shares of the company's stock after acquiring an additional 1,941,993 shares during the period. Citigroup Inc. owned 0.49% of agilon health worth $7,971,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock valued at $176,582,000 after purchasing an additional 371,537 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock valued at $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC boosted its stake in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock valued at $5,262,000 after acquiring an additional 316,856 shares during the last quarter. Simplicity Wealth LLC increased its position in agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company's stock worth $171,000 after purchasing an additional 15,515 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in agilon health during the 2nd quarter worth about $1,849,000.
Insider Activity
In other agilon health news, CEO Steven Sell purchased 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company's stock, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.20% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on AGL. Citigroup decreased their price target on shares of agilon health from $2.50 to $1.75 and set a "sell" rating on the stock in a research note on Wednesday, November 13th. Royal Bank of Canada restated an "outperform" rating and set a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Stifel Nicolaus reduced their price target on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research note on Tuesday, November 12th. JMP Securities cut agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Finally, TD Cowen dropped their target price on agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a research note on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $6.05.
View Our Latest Stock Report on agilon health
agilon health Trading Down 0.9 %
AGL traded down $0.02 during trading on Friday, hitting $2.09. 2,838,072 shares of the company's stock were exchanged, compared to its average volume of 4,926,008. The stock has a 50 day moving average price of $2.76 and a 200 day moving average price of $4.66. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $13.76. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $861.12 million, a P/E ratio of -2.23 and a beta of 0.60.
agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same period last year, the company posted ($0.06) earnings per share. As a group, analysts expect that agilon health, inc. will post -0.47 EPS for the current fiscal year.
agilon health Company Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
